SUNNYVALE, Calif., Jan. 7, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that it will report results for its second quarter of fiscal 2014, ended December 31, 2013 on Thursday, January 30, 2014 after the market closes.
A conference call to review the results will begin at 1:30 p.m. PST/ 4:30 p.m. EST and will be hosted by Joshua H. Levine, president and chief executive officer and Gregory Lichtwardt, executive vice president, operations and chief financial officer both of Accuray.
The conference call dial-in numbers are 1-866-318-8618 ( USA) or 1-617-399-5137 (International), Conference ID: 52092679. In addition, a dial-up replay of the conference call will be available beginning January 30, 2014 at 5:30 p.m. PST/ 8:30 p.m. EST and ending on February 6, 2014. The replay telephone number is 1-888-286-8010 ( USA) or 1-617-801-6888 (International), Conference ID: 37382502.
A live webcast of the call will also be available from the Investor Relations section of the company's website at http://www.accuray.com/investors . A webcast replay can be accessed on the website beginning Thursday, January 30, 2014 at approximately 4:30 p.m. PST/ 7:30 p.m. EST. The replay will remain available until Accuray announces its results for the third quarter of fiscal 2014, ending March 31, 2014.About AccurayAccuray Incorporated (Nasdaq: ARAY), is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com. SOURCE Accuray Incorporated
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts